2 Signals to Watch After Micron's Earnings

Micron reported fiscal Q2 revenue of $24.0B, up 195% YoY, and net income of ~$14B versus $1.6B a year ago, and guided fiscal Q3 midpoint revenue of $33.5B (implying ~260% YoY growth). Management plans $25B in fiscal 2026 capex while holding about $14.5B in liquidity; Bloomberg Intelligence projects HBM market CAGR of 42% through 2033. Despite the blowout results and strong outlook, shares fell as investors remain skittish on AI valuations, heavy capex and semiconductor cyclicality.

Analysis

Market action after the print looks less like a signal about near-term demand and more like re-pricing of two risks: sustained heavy capex and concentrated market structure. Micron sits on pricing power for HBM but also on a capital schedule that can force financing choices within 12–24 months; how they fund capex will determine whether shareholders capture operating leverage or bear dilution.

Second-order winners are participants that sit between HBM scarcity and GPU OEMs — memory test/assembly partners, logistics nodes that shorten cycle times, and large OEMs that can secure long-term supply (which raises switching costs for smaller customers). Conversely, any entrant that meaningfully reduces lead times (via foundry partnerships or backward integration) would compress Micron’s margin premium faster than an aggregate demand slowdown would.

Near-term reversal triggers are simple and fast: a visible pullback in hyperscaler HBM bookings (weeks–quarters) or an announced equity/dilutive financing plan. Medium-term reversal (12–36 months) would come from architectural change — either a software-driven reduction in HBM dependency or a new memory form factor that disintermediates today’s high-bandwidth stacks. Absent either, the structural setup favors ownership but with asymmetric event risk tied to funding and supply concentration.

Key Decisions for Investors

• Buy MU equity sized 1.5% NAV (12‑month target +60–80%, stop‑loss 30%). Rationale: asymmetric upside from continued HBM tightness; hedge execution/dilution risk by purchasing a 9‑month 25% OTM put sized at 0.3% NAV to cap downside.
• Pair trade — Long MU / Short INTC equal dollar (12 months). Thesis: MU benefits from HBM scarcity and superior free‑cash conversion on per‑chip economics while INTC’s heavy capex and foundry pivot compress returns; expect relative outperformance of MU by 40–60% if trends persist. Risk: INTC execution surprise (process node wins) can flip the pair quickly; size at 1% NAV each side.
• Buy MU Jan‑2027 LEAP calls (delta ~0.40) funded by selling Jan‑2025 20–25% OTM calls (calendar finance). This creates convex long exposure to ongoing HBM adoption while monetizing near-term implied vol to reduce carry. Reward: 3x+ upside if HBM pricing and shipments remain strong; downside: full premium loss if AI capex stalls within 12 months.
• Protect portfolio AI exposure with a tactical NVDA hedge — buy 6‑month 15–20% OTM put spread (small size 0.5% NAV). NVDA acts as a liquidity/sentiment proxy for AI risk‑off; this inexpensive hedge limits portfolio drawdown should AI enthusiasm reverse sharply in the next 3–6 months.